Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Guixiang Dai"'
Autor:
Chenxiao Wang, Mst Shamima Khatun, Zhe Zhang, Michaela J. Allen, Zheng Chen, Calder R. Ellsworth, Joshua M. Currey, Guixiang Dai, Di Tian, Konrad Bach, Xiao-Ming Yin, Vicki Traina-Dorge, Jay Rappaport, Nicholas J. Maness, Robert V. Blair, Jay K. Kolls, Derek A. Pociask, Xuebin Qin
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-14 (2023)
Abstract SARS-CoV-2 infection can cause persistent respiratory sequelae. However, the underlying mechanisms remain unclear. Here we report that sub-lethally infected K18-human ACE2 mice show patchy pneumonia associated with histiocytic inflammation a
Externí odkaz:
https://doaj.org/article/15de162092a24f62b3a66615cbf80085
Autor:
Ferris T. Munyonho, Robert D. E. Clark, Dong Lin, Mst Shamima Khatun, Dora Pungan, Guixiang Dai, Jay K. Kolls
Publikováno v:
mBio, Vol 15, Iss 1 (2024)
ABSTRACTPneumocystis pneumonia (PCP) is a serious fungal lung infection caused by Pneumocystis jirovecii in immunosuppressed individuals. The lack of viable in vitro/ex vivo PCP models has greatly hindered the progress in studying the biology of thes
Externí odkaz:
https://doaj.org/article/080558282dc44dfdb9f8d49f914cd551
Publikováno v:
Haiyang Kaifa yu guanli, Vol 40, Iss 2, Pp 115-124 (2023)
Based on the survey results of Spartina alterniflora, sediments, and intertidal benthic organisms in Zhangjiang Estuary Mangrove Reserve in 2019 and 2020, and combined with historical remote sensing image data, this paper analyzed the invasion proces
Externí odkaz:
https://doaj.org/article/9a3eb0663575412bb6ab0cff59322e06
Publikováno v:
Haiyang Kaifa yu guanli, Vol 39, Iss 4, Pp 34-38 (2022)
In order to effectively prevent and control the impact of reclamation activities on the marine ecological environment, according to the relevant technical guidelines, taking the pressure of habitat, organisms and ecosystem as the index, and based on
Externí odkaz:
https://doaj.org/article/5f53a60be4384c1aafb2a977aa9372b1
Autor:
Kristin Noell, Guixiang Dai, Dora Pungan, Anna Ebacher, Janet E. McCombs, Samuel J. Landry, Jay K. Kolls
Publikováno v:
JCI Insight, Vol 7, Iss 17 (2022)
Pneumocystis is the most common fungal pulmonary infection in children under the age of 5 years. In children with primary immunodeficiency, Pneumocystis often presents at 3–6 months of age, a time period that coincides with the nadir of maternal Ig
Externí odkaz:
https://doaj.org/article/dabb1d72bf4a42cca8fd8aeb0b069a44
Autor:
Dora Pungan, Jia Fan, Guixiang Dai, Mst Shamima Khatun, Monika L. Dietrich, Kevin J. Zwezdaryk, James E. Robinson, Samuel J. Landry, Jay K. Kolls
Publikováno v:
Journal of Fungi, Vol 9, Iss 6, p 602 (2023)
Pneumocystis jirovecii is the most common cause of fungal pneumonia in children under the age of 2 years. However, the inability to culture and propagate this organism has hampered the acquisition of a fungal genome as well as the development of reco
Externí odkaz:
https://doaj.org/article/cbd67d68a13246a49e0eb1c3f9cdc987
Publikováno v:
mSphere, Vol 6, Iss 3 (2021)
Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with PneumocystisPneumocystis
Externí odkaz:
https://doaj.org/article/f0f0b4cd8cad40f0b7cab1d5bb3c5cd3
Publikováno v:
JCI Insight, Vol 6, Iss 2 (2021)
Pneumocystis is an important opportunistic fungus that causes pneumonia in children and immunocompromised individuals. Recent genomic data show that divergence of major surface glycoproteins may confer speciation and host range selectivity. On the ot
Externí odkaz:
https://doaj.org/article/572f9d6afded44dbab277682afe1854c
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148701 (2016)
Flagellin has been tested as a protein-based vaccine adjuvant, with the majority of studies focused on antibody responses. Here, we evaluated the adjuvant activity of flagellin for both cellular and humoral immune responses in BALB/c mice in the sett
Externí odkaz:
https://doaj.org/article/11eedbf40f8b4d9c9936a7a73aa12aea
Publikováno v:
mSphere, Vol 6, Iss 3 (2021)
mSphere
mSphere
Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with Pneumocystis pneumonia in humans. This study shows that low-dose subcutaneous anti-CD20 can modulate B cell populations without grossly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::480af20908d0cc3c95b69d526ed6d3a2
https://journals.asm.org/doi/10.1128/mSphere.01144-20
https://journals.asm.org/doi/10.1128/mSphere.01144-20